September 20,2018

September 20,2018

Rubius Therapeutics to Participate in the Leerink Partners Roundtable Series: Rare Disease & Immuno-Oncology
Read More

OURSCIENCE

Red-Cell Therapeutics products are an innovative new class of medicines which address a wide array of diseases and disorders.

Learn More

OURFOCUS

Rubius® is developing a new class of medicines to address a wide array of indications, with leading applications in rare disease, cancer and autoimmune disease

Learn More

Careers

We are building a company dedicated to dramatically improving the lives of patients living with serious diseases.

Join Our Team